Oncocorner

Webinar

Jul
2024

00
CEST

Gastrointestinal cancer highlights from AACR Annual Meeting 2024, ASCO Annual Meeting 2024, and ESMO GI Cancers Congress 2024

Gastrointestinal (GI) cancers are among the most common and deadly worldwide. Recent advancements in minimally invasive surgery, targeted therapies, and immunotherapy are improving survival rates. Molecular insights are driving personalised treatment approaches, significantly enhancing patient outcomes. This webinar will explore these breakthroughs and future directions in GI cancer care.

Speakers

Discussant

Ducreux Michel

Head of GI Oncology Unit, Department of Medical Oncology, at Gustave Roussy, Villejuif, France

Expert

Macarulla Teresa

Group Leader of Gastrointestinal and Endocrine Tumors Group and Noncolorectal GI Cancer Translational Research Group at the Vall d'Hebron University Hospital, Barcelona, Spain

Expert

Smyth Elizabeth

Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom